Beta-Adrenergic Receptor Locations
Beta-adrenergic receptors are distributed throughout the body with β1 receptors located primarily in the myocardium (heart muscle), and β2 receptors located primarily in vascular and bronchial smooth muscle. 1, 2
Specific Receptor Subtypes and Their Locations
Beta-1 Adrenergic Receptors
- Myocardium (heart muscle) - This is the predominant location 1, 2, 1
- Cardiac tissues including the sinus node and AV node 1
- Kidneys 3
When β1 receptors are stimulated by catecholamines, they increase:
- Myocardial contractility (positive inotropy)
- Heart rate (positive chronotropy)
- AV node conduction velocity 1, 2
Beta-2 Adrenergic Receptors
- Vascular smooth muscle - throughout blood vessels 1, 2
- Bronchial smooth muscle - in the airways 1, 2
- Alveolar epithelium in the lungs 4
- Uterine muscle 5
- Bladder muscle 5
- Gastrointestinal tract smooth muscle 5
- Liver (involved in glycogenolysis) 3
- Adipose tissue (involved in fat metabolism) 3
β2 receptor stimulation causes vasodilation and bronchodilation, while their inhibition produces vasoconstriction and bronchoconstriction 1, 2.
Beta-3 Adrenergic Receptors
- White and brown adipose tissue (fat cells) 5
- Heart 6
- Urinary bladder detrusor muscle 6
- Gastrointestinal tract 6
- Brain 6
Additional Distribution Sites
Beta-adrenergic receptors are also found in:
- Central nervous system - particularly high concentrations in hippocampus, cerebellum, thalamic nuclei, basal ganglia, and cerebral cortex 7
- Eye structures - iris-ciliary body (predominantly β2 subtype) 8
- Pulmonary system - systemic blood vessels and cardiac tissues 3
Clinical Relevance
Understanding these locations is critical because:
- β1-selective blockers primarily affect the heart (reducing heart rate, contractility, and blood pressure)
- Non-selective beta blockers affect both cardiac function AND cause bronchoconstriction/vasoconstriction through β2 blockade 1, 2
- This distribution pattern explains why non-selective beta blockers can worsen bronchospasm in patients with reactive airway disease 1